Patient Choice Cards

Prostate Cancer Canada is pleased to partner with InnoviCares and RxHelp One™, two FREE programs sponsored by pharmaceutical manufacturers that give you access to dozens of brand name medications and medical devices at little or no cost versus the generic alternative.

To learn more about these FREE programs, which medications and healthcare products are covered and how you can participate in these programs, simply click on the links below.


InnoviCares

InnoviCares is a FREE patient benefit plan that gives you coverage for a variety of medications, plus savings on many healthcare products – giving you greater access and choice to nearly 100 brand name medications. To see which medications and healthcare products are available to you and to sign up to receive this benefit, click here: https://prostatecancer.innovicares.ca

InnoviCares-Graphic.png


RxHelp One

RxHelp ONE™ is FREE, and gives you access to dozens of brand medications, including treatments for men’s health, all at little or no cost versus the generic alternative. To see what medications are covered and to sign up, click here: www.RxHelpONE.com/PCC

RxHelp One



If you have questions about joining these programs, please contact us: drugcoverage@prostatecancer.ca
 


Prostate Cancer Canada is proud to partner with RxHelp One™ and InnoviCares to offer these FREE programs as another choice for patients who wish to remain on their brand name medications, however, this is not an endorsement. PCC believes patients should choose medications that are right for them based on informed discussions with their healthcare providers.
 




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More

Prostate Cancer Canada announces new President and CEO

Toronto, December 21, 2017 – After five successful years under the leadership and guidance of outgoing President and CEO, Rocco Rossi, Prostate Cancer Canada (PCC) is excited to announce the appointment of a most worthy successor in Peter Coleridge, past national CEO of the Canadian Mental Health Association and current national President and CEO of Big Brothers Big Sisters of Canada.
More

Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.
More


Click here for news archive